SISCAPA Assay Technologies
Ms. Seniff has a background in international business and biotechnology, including proteomics and diagnostics. She managed the business activities of Large Scale Biology Corporation through a startup phase that lead to a successful IPO in 2000, and has managed the financial affairs of SAT since its inception. Ms. Seniff holds a BSc with honors in Business from Florida State University.
This person is not in any offices
SISCAPA Assay Technologies
SISCAPA technology is the smart shortcut to the sensitive quantitation of protein biomarkers and targets. SISCAPA assays combine the precision of MRM mass spectrometry with the power of affinity enrichment to deliver a superior alternative to conventional immunoassays for protein quantitation.